United States Patent Application 20180161282 Methods and compositions for the treatment of seizure-related disorders by Adamas Biopharmaceutical Inc. (https://www.adamaspharma.com/) includes references to iPRECIO Micro Infusion Pump use in Examples 13 to 16. In example 13, “The PK parameters (Cmax, Tmax, T1/2, AUC) of 200 mg IR lacosamide BID and 400 mg ER lacosamide QD in humans can be replicated in rats using programmable subcutaneous infusion pumps. ”. For more information, see https://patents.google.com/ or http://appft.uspto.gov.

"The iPRECIO pump enables reliable, timed delivery of pharmacological agents. The pump was programmed for 1 hour delivery of Isoproterenol at 30ul/hr, total dose of 2mg/kg/day, once a day at the same time (1pm)” 4/5 week study duration.

Swati Dey et al., Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure Circulation Research. 2018;CIRCRESAHA.118.312708, originally published June 13, 2018 https://doi.org/10.1161/CIRCRESAHA.118.312708

RenaSci (http://www.renasci.co.uk/news/iprecio-micro-infusion-pumps) are now offering chronic administration of drugs via implantable, programmable, refillable, micro infusion iPRECIO^® pumps.

Experimental Biology iPRECIO Micro Infusion Pump on booth 936.
Learn how iPRECIO^™ Micro Infusion Pumps can make your research easier. Also, how our customers have been using our pumps, how we have helped them with their research goals and where they have been publishing. Also ask us for our recently updated Example Applications & much more booklet which summarizes data from peer reviewed articles and presentations.

Together with RRSSC (http://www.rrssc.eu/) Primetech organizes a course in iPRECIO pump implantation. Participants can choose between a 3-day course for basic implantation techniques or a 5-day course for more complicated techniques. Look <click here> for the program.

The first course is planned from June 11th to 15th 2018. Please register directly with RRSSC; http://www.rrssc.eu/application-form.php.